Antibody Production Services Ltd. specializes in advanced antibody production technologies, focusing on the development and optimization of monoclonal and polyclonal antibodies. The company employs hybridoma technology for monoclonal antibody generation, which involves the fusion of myeloma cells with B cells from immunized animals. This process allows for the creation of stable cell lines that produce specific antibodies, ensuring high specificity and affinity for target antigens. Additionally, the company utilizes various purification techniques to isolate and refine antibodies, ensuring high purity and functionality for research and therapeutic applications.

In addition to traditional antibody production methods, Antibody Production Services Ltd. incorporates innovative approaches such as recombinant antibody technology. This technique enables the engineering of antibodies with enhanced properties, including improved stability and reduced immunogenicity. The company also emphasizes the importance of rigorous quality control measures throughout the production process, ensuring that the antibodies meet the stringent requirements for both research and clinical use. By leveraging these technologies, Antibody Production Services Ltd. aims to provide high-quality antibody products that support advancements in biomedical research and therapeutic development.

United Kingdom

northside house, bedford, herts, united kingdom

Antibody Production Services Ltd.

Company Details